The Bind Therapeutics ticker is BIND and it is traded on the Nasdaq Global Market.
The company's initial public offering (IPO) priced on September 19, 2013.
325 Vassar Street, Cambridge, MA 02139
You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.
You can view our management team by visiting the Management section of our Investor Relations website.
Bind Therapeutics does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.
Bind Therapeutics does not currently have a direct stock purchase plan.
Where can I find all of Bind Therapeutics's SEC filings? Where can I download and view quarterly and annual reports?
Please submit your question using the form below. * Required fields